Sign in
SCHEDULE 13G

Statement of Beneficial Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000902664-25-000860

Stakes reported in this filing

Loading xslSCHEDULE_13G_X01/primary_doc.xml…